Ondine Biomedical (FRA:VF5) Shares Buyback Ratio %: -16.90 (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VF5 Ondine Biomedical Inc FRA:VF5
29 GF Score
Price €0.10
GF Value €0.11
! 7 Warning Signs
View Full Analysis

What is Ondine Biomedical Shares Buyback Ratio %?

Ondine Biomedical FRA:VF5 -6.25% 29 Shares Buyback Ratio % is -16.90 as of Sep. 21, 2026. GuruFocus rates FRA:VF5 with a GF Score™ of 29/100 and a GF Value™ of €0.11. The stock has 7 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Ondine Biomedical's current shares buyback ratio was -16.90%.

Ondine Biomedical Shares Buyback Ratio % Related Terms

Ondine Biomedical Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Ondine Biomedical's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical Shares Buyback Ratio % Chart

Ondine Biomedical Annual Data
Trend Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 -16.53 -78.17 -28.31

Ondine Biomedical Semi-Annual Data
Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.29 -22.29 -45.70 -9.76 -16.90
FRA:VF5
29GF Score
Ondine Biomedical Inc FRA:VF5
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ondine Biomedical Shares Buyback Ratio % Calculation

Ondine Biomedical's Shares Buyback Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(404.004731 - 518.366964) / 404.004731
=-28.31%

Ondine Biomedical's Shares Buyback Ratio for the quarter that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2025 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Jun. 2025 )
=(443.433174 - 518.366964) / 443.433174
=-16.90%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -16.90 mean?
Ondine Biomedical (FRA:VF5) has a Shares Buyback Ratio % of -16.90 as of Sep. 21, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Ondine Biomedical and its competitors.
Is Ondine Biomedical's Shares Buyback Ratio % too high?
Ondine Biomedical's current Shares Buyback Ratio % is -16.90. Overall, Ondine Biomedical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Ondine Biomedical's Shares Buyback Ratio % compare to VRTX and REGN?
Ondine Biomedical's Shares Buyback Ratio % of -16.90 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Biotechnology company?
A good Shares Buyback Ratio % depends on the Biotechnology industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Ondine Biomedical and its competitors. Ondine Biomedical's current Shares Buyback Ratio % is -16.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ondine Biomedical stock overvalued right now?
Ondine Biomedical (FRA:VF5) has a current Shares Buyback Ratio % of -16.90. The stock's GF Value™ is €0.11, compared to a current price of €0.10 — trading 11.4% below its estimated fair value. The current Shares Buyback Ratio % is -16.90. Ondine Biomedical's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Ondine Biomedical (FRA:VF5), the current Shares Buyback Ratio % is -16.90 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ondine Biomedical (FRA:VF5) Overvalued in 2026?

Based on GuruFocus' analysis, Ondine Biomedical stock appears to be undervalued. The current stock price of €0.10 is trading 11.4% below its estimated GF Value™ of €0.11.

Key valuation signals for FRA:VF5:

  • Shares Buyback Ratio %: -16.90
  • GF Value™: €0.11 vs. price of €0.10 (11.4% below fair value)
  • GF Score™: 29/100 with 7 warning signs

No single metric tells the full story. See the FRA:VF5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ondine Biomedical Business Description

Other Exchanges OBIMF:USAOBI:UK
Address 1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
29GF Score

Get the complete analysis for FRA:VF5

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.11
GF Value